Indicators

Markets:

News

Latest News about ATAI

Recent news which mentions ATAI

< Previous 1 2 3 4 5 6 7 8 9

...

Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More

December 18, 2023

MindMed’s stock boosted by positive data in trial of LSD as treatment for anxiety disorder

December 14, 2023

Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More

December 11, 2023

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More

December 05, 2023

Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More

November 24, 2023

GH Research, Compass Pathways Among Top Psychedelic Movers Of Today

November 23, 2023

Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2

November 21, 2023

Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026

November 14, 2023

Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More

November 12, 2023

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More

November 06, 2023

Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More

October 29, 2023

Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted

October 22, 2023

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

October 16, 2023

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More

October 06, 2023

Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation

October 03, 2023

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

October 02, 2023

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More

September 26, 2023

Exclusive Insights: How Tech Leaders Are Finding Balance Through Microdosing Psychedelics

September 23, 2023

Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More

September 18, 2023

Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update

September 18, 2023

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years

September 12, 2023

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More

September 11, 2023

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

September 05, 2023

Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More

August 28, 2023

Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports

August 21, 2023

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More

August 14, 2023

Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA

August 10, 2023

Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration

August 09, 2023

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More

August 03, 2023

Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial

July 28, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.